|
|
 |
I'm training to be an engineer para que serve o cloridrato de ciprofloxacino de 500 mg
Speaking at a briefing in Washington to raise awareness of the drug review process, Dr. Jay Siegel, head of global regulatory affairs at Johnson & Johnson, said he expects two years to be knocked off the time it would typically take the FDA to review ibrutinib, the company's experimental cancer drug.
2021-3-17 5:16:49 |
|
|
|
